Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NAVB
7051
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $23K | ﹤0.01% |
+2,005
| New | +$22.8K |
2017 Q1
0 quarters
|
|
|
GIGA
7052
DELISTED
Giga-Tronics Inc
GIGA
| $23K | ﹤0.01% |
+28,802
| New | +$24.5K |
2017 Q1
0 quarters
|
|
|
HH
7053
DELISTED
Hooper Holmes Inc
HH
| $23K | ﹤0.01% |
27,736
+1,364
| +5% | +$1.12K |
2016 Q2
3 quarters
|
|
|
ORIG
7054
CALL
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $23K | ﹤0.01% |
9
-6
| -40% | -$62.1K |
2014 Q1
12 quarters
|
|
|
KIQ
7055
DELISTED
Kelso Technologies Inc.
KIQ
| $23K | ﹤0.01% |
29,892
+13,909
| +87% | +$12.9K |
2016 Q3
2 quarters
|
|
7056
Digital Turbine
APPS
$1.35B
| $22K | ﹤0.01% |
+23,558
| New | +$18.5K |
2017 Q1
0 quarters
|
|
7057
CALL
Intrepid Potash
IPI
$441M
| $22K | ﹤0.01% |
1,280
+30
| +2% | +$580 |
2016 Q4
1 quarter
|
|
7058
Protara Therapeutics
TARA
$160M
| $22K | ﹤0.01% |
+312
| New | +$23.3K |
2017 Q1
0 quarters
|
|
7059
Tempest Therapeutics
TPST
$13.7M
| $22K | ﹤0.01% |
4
| – | – |
2016 Q4
1 quarter
|
|
|
JRJR
7060
DELISTED
JRjr33, Inc.
JRJR
| $22K | ﹤0.01% |
47,851
+18,959
| +66% | +$13K |
2016 Q1
4 quarters
|
|
|
UNXL
7061
PUT
DELISTED
Uni-Pixel, Inc.
UNXL
| $22K | ﹤0.01% |
25,700
-17,300
| -40% | -$19.1K |
2016 Q2
3 quarters
|
|
|
ZX
7062
DELISTED
China Zenix Auto Internatl Ltd
ZX
| $22K | ﹤0.01% |
13,766
-10,262
| -43% | -$14.8K |
2016 Q4
1 quarter
|
|
7063
Emerson Radio
MSN
$8.29M
| $21K | ﹤0.01% |
15,728
-19,703
| -56% | -$23.3K |
2016 Q4
1 quarter
|
|
|
7064
CALL
Tempest Therapeutics
TPST
$13.7M
| $21K | ﹤0.01% |
+4
| New | +$18.6K |
2017 Q1
0 quarters
|
|
|
TISA
7065
DELISTED
TOP Image Systems Ltd
TISA
| $21K | ﹤0.01% |
+15,759
| New | +$22.2K |
2017 Q1
0 quarters
|
|
7066
Moleculin Biotech
MBRX
$9.92M
| $20K | ﹤0.01% |
+8
| New | +$28K |
2017 Q1
0 quarters
|
|
|
NCTY
7067
The9 Ltd
NCTY
$50.4M
| $20K | ﹤0.01% |
64
+27
| +73% | +$8.83K |
2016 Q4
1 quarter
|
|
7068
Ocugen
OCGN
$346M
| $20K | ﹤0.01% |
+193
| New | +$19.5K |
2017 Q1
0 quarters
|
|
|
PPBT
7069
Purple Biotech
PPBT
$2.46M
| $20K | ﹤0.01% |
+5
| New | +$23.9K |
2017 Q1
0 quarters
|
|
7070
Tantech Holdings
TANH
$9.87M
| – | – |
0
| – | – |
2017 Q1
0 quarters
|
|
|
BSIN
7071
Big Sky Industrial
BSIN
$74.5M
| $20K | ﹤0.01% |
+2,286
| New | +$22.7K |
2017 Q1
0 quarters
|
|
|
NEPT
7072
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $20K | ﹤0.01% |
14
-24
| -63% | -$35.4K |
2016 Q3
2 quarters
|
|
|
CYTO
7073
DELISTED
Altamira Therapeutics Ltd
CYTO
| – | – |
0
| – | – |
2016 Q3
2 quarters
|
|
|
NMTR
7074
DELISTED
9 Meters Biopharma
NMTR
| $20K | ﹤0.01% |
84
| – | – |
2016 Q4
1 quarter
|
|
|
PLXP
7075
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $20K | ﹤0.01% |
+1,913
| New | +$20.8K |
2017 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.